Pharmacy Times

Pharmacy Times is a monthly magazine aimed at pharmacists, published by Intellisphere, LLC. It offers valuable clinical insights that pharmacists can apply in their daily work. Every issue includes articles and features on various topics such as pharmacy trends, medication mistakes, drug interactions, educating patients, pharmacy technology, managing diseases, counseling patients, updates on products, pharmacy regulations, and specialty pharmacy. The magazine is located in Plainsboro, New Jersey.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#123917

United States

#35892

Health/Health

#837

Traffic sources

Monthly visitors

Articles

FDA Approves Brekiya, First and Only DHE Autoinjector, for Acute Treatment of Migraine, Cluster Headaches

1 day ago | pharmacytimes.com | Gillian McGovern

The FDA approved a dihydroergotamine (DHE) mesylate injection (Brekiya; Amneal Pharmaceuticals), the first and only DHE autoinjector, for the acute treatment of migraine with or without aura and cluster headaches in adult patients.
CVS Health Announces It Will Drop Zepbound and Prioritize Coverage of Wegovy

2 days ago | pharmacytimes.com | Gillian McGovern

On Thursday, May 1, 2025, CVS Health announced that beginning July 1, 2025, its pharmacy benefit manager (PBM) division will drop tirzepatide (Zepbound; Eli Lilly and Co.) from its preferred formulary list and instead prioritize coverage of semaglutide (Wegovy; Novo Nordisk). According to an article by Forbes, this decision appears to be a move in a broader set of battles that involves competing pharmaceutical companies, PBMs, and pharma and direct-to-consumer telehealth companies.
Anitocabtagene Autoleucel Yields Overall Response Rate of 97% in Patients With Multiple Myeloma

2 days ago | pharmacytimes.com | Alexandra Gerlach

Anitocabtagene autoleucel (anito-cel; Arcellx, Inc.) demonstrated significant response rates and minimal residual disease (MRD) negativity in patients with relapsed or refractory multiple myeloma (RRMM).
Engaging in Research and Disseminating Information Are Essential For All Stakeholders, Experts Say

2 days ago | pharmacytimes.com | Gillian McGovern

As science and medicine continue to rapidly advance, effective communication is necessary for translating research findings into real improvements in patient care, explained panelists at a Center for Innovation & Value Research 2025 Methods Summit panel discussion held on March 19 in Washington, DC.
Ixchiq Vaccine Linked to Fatal Adverse Events in Seniors, the FDA and CDC Urge Caution

3 days ago | pharmacytimes.com | Alexandra Gerlach

The FDA and CDC made a joint announcement advising against inoculation against chikungunya infection with the Ixchiq vaccine (Valneva) for older adults ages 60 and older. The recommendation comes amid 2 fatalities and 17 adverse effects (AE), mainly neurologic and cardiac events.1Chikungunya infection is a viral illness spread through mosquito bites, more commonly found in tropical and subtropical regions of Africa, Southeast Asia, and portions of the Americas.
President Trump Signs Executive Order Aiming to Lower Prescription Drug Costs by Up to 90%

3 days ago | pharmacytimes.com | Alexandra Gerlach

President Donald J. Trump has signed the executive order (EO) “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” which aims to reduce drug costs for Americans and tie them to what other nations pay for medications.
Community Behavioral Health Clinics Can Be Instrumental in Switching Patients to Long-Acting Injectable Antipsychotics

3 days ago | pharmacytimes.com | Aislinn Antrim

Research findings presented at the American Association of Psychiatric Pharmacy (AAPP) 2025 meeting provide a framework for how certified community behavioral health clinics (CCBHCs) can be crucial partners in switching patients with serious mental illness to long-acting injectable (LAI) antipsychotic therapies with a longer duration.1Long-Acting Injectable TherapiesLAIs represent a significant advancement in the treatment of serious mental illnesses like schizophrenia and bipolar disorder.
May 2025 Pharmacy Policy

3 days ago | pharmacytimes.com | Aislinn Antrim

Arkansas Law Bans PBM-Owned PharmaciesOn April 16, Arkansas Gov Sarah Huckabee Sanders signed into law House Bill 1150, which bans state permits to pharmacies owned by pharmacy benefit managers (PBMs). The law will take effect January 1, 2026.1Supporters of this bill say it will help end PBM tactics that have long been seen as unfair to pharmacies, such as patient steering, below-cost reimbursements, and punitive audit practices.
Multicomponent COVID-19-Influenza Vaccine Induces Higher Immune Responses Than Standard Care Immunizations

4 days ago | pharmacytimes.com | Luke Halpern

mRNA-1083, a multicomponent vaccine designed to protect against seasonal influenza and SARS-CoV-2, was found to induce higher immune responses compared with recommended standard care influenza (standard and high dose) and COVID-19 vaccines against a variety of strains that can sicken patients with an acceptable safety and tolerability profile, according to results from a phase 3, randomized, observer-blinded trial (NCT06097273) published in the Journal of the American Medical Association.1,2...
Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

4 days ago | pharmacytimes.com | Alexandra Gerlach

In this episode of the Pharmacy Times Peer Exchange feature series about antibody drug conjugates (ADCs) and human epidermal growth factor receptor 2 (HER2) breast cancer (BC), oncology pharmacists discuss novel, emerging ADCs and real-world management of these therapies.

Contact details

Address

123 Example Street

City, Country 12345

Phone

+1 (555) 123-4567

Socials

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Outlet metrics

Articles

FDA Approves Brekiya, First and Only DHE Autoinjector, for Acute Treatment of Migraine, Cluster Headaches

CVS Health Announces It Will Drop Zepbound and Prioritize Coverage of Wegovy

Anitocabtagene Autoleucel Yields Overall Response Rate of 97% in Patients With Multiple Myeloma

Engaging in Research and Disseminating Information Are Essential For All Stakeholders, Experts Say

Ixchiq Vaccine Linked to Fatal Adverse Events in Seniors, the FDA and CDC Urge Caution

President Trump Signs Executive Order Aiming to Lower Prescription Drug Costs by Up to 90%

Community Behavioral Health Clinics Can Be Instrumental in Switching Patients to Long-Acting Injectable Antipsychotics

May 2025 Pharmacy Policy

Multicomponent COVID-19-Influenza Vaccine Induces Higher Immune Responses Than Standard Care Immunizations

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Pharmacy Times journalists

Contact details

Address

Phone

Email

Email Patterns

Website

Socials

Traffic locations

Related outlets